NCT06394297

VIBE - Virtual Image Guided Brachytherapy Emulation for Locally Advanced Cervical Cancer (LACC)

Name: Clinical Trial NCT06394297
Creator: Fundacao Champalimaud
Keywords: Cervical Cancer, SBRT, radiation, clinical trial, Portugal

A Phase I/II Study for Image Guided Stereotactic Body Radiation Therapy Boost for Definitive Treatment of Locally Advanced Cervical Cancer (LACC)

Fundacao Champalimaud·ClinicalTrials.gov·radiationRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Cervical Cancer
Drug/Device/Intervention: SBRT
Study type: Interventional
Intervention type: radiation

Sponsor & location

Primary sponsor: Fundacao Champalimaud
Location: Lisboa, Portugal

Timeline & enrollment

Phase: N/A
Start date: Aug 04, 2023
End date: Aug 04, 2026
Enrollment: 30 participants

Primary outcome

Dosimetric Feasibility of SBRT boost,reproducibility of SBRT boost,Inter/intra fractional target motion,Adverse Events,Local control

Summary

This study will evaluate the role of SBRT with the aim to reproduce high dose rate brachytherapy (HDR BT) dose distribution by means of external beam radiotherapy in the radical treatment in patients with LACC. The study will employ devices to accurately reproduce pelvic anatomy and mitigate target motion and will make use of real-time online tracking.

ICD-10 classifications

Severe cervical dysplasia, not elsewhere classifiedMild cervical dysplasiaModerate cervical dysplasiaCarcinoma in situ: Cervix, unspecifiedCervical root disorders, not elsewhere classified

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06394297
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06394297 through Pure Global AI's free database. This phase not specified trial is sponsored by Fundacao Champalimaud and is currently Recruiting. The study focuses on Cervical Cancer. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.